Laboratory detection and clinical implication of oxacillinase-48 like carbapenemase: The hidden threat

Journal of Global Infectious Diseases

Volumn 8, Issue 1, 2016, Pages 41-50

  Bakthavatchalam, Yamuna Devi ^a   Anandan, Shalini ^a   Veeraraghavan, Balaji ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Carbapenemase; noscomial; OXA 48; OXA 48 like

Indexed keywords

BACTERIAL ENZYME; CARBAPENEM; CARBAPENEMASE; CEPHALOSPORIN DERIVATIVE; OXACILLINASE 163; OXACILLINASE 48; TEMOCILLIN; UNCLASSIFIED DRUG;

BACTERIAL GENE; CHROMOGENIC MEDIUM; CULTURE TECHNIQUE; DISK DIFFUSION; DRUG HYDROLYSIS; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; LABORATORY TEST; MINIMUM INHIBITORY CONCENTRATION; MODIFIED HODGE TEST; NONHUMAN; PHENOTYPE; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SPECIES DISTRIBUTION;

EID: 84958986174     PISSN: 0974777X     EISSN: 09748245     Source Type: Journal    
DOI: 10.4103/0974-777X.176149     Document Type: Review

References (103)

1. Perez F, Van Duin D. Carbapenem-resistant Enterobacteriaceae: A menace to our most vulnerable patients. Cleve Clin J Med 2013;80:225-33
2. Temkin E, Adler A, Lerner A, Carmeli Y. Carbapenem-resistant Enterobacteriaceae: Biology, epidemiology, and management. Ann N Y Acad Sci 2014;1323:22-42
3. Miriagou V, Cornaglia G, Edelstein M, Galani I, Giske CG, Gniadkowski M, et al. Acquired carbapenemases in Gram-negative bacterial pathogens: Detection and surveillance issues. Clin Microbiol Infect 2010;16:112-22
4. Poirel L, Pitout JD, Nordmann P. Carbapenemases: Molecular diversity and clinical consequences. Future Microbiol 2007;2:501-12
5. Antunes NT, Lamoureaux TL, Toth M, Stewart NK, Frase H, Vakulenko SB. Class D ®-lactamases: Are they all carbapenemases? Antimicrob Agents Chemother 2014;58:2119-25
6. Potron A, Poirel L, Rondinaud E, Nordmann P. Intercontinental spread of OXA-48 beta-lactamase-producing Enterobacteriaceae over a 11-year period, 2001 to 2011. Euro Surveill 2013;18. pii: 20549
7. Poirel L, Naas T, Nordmann P. Diversity, epidemiology, and genetics of class D beta-lactamases. Antimicrob Agents Chemother 2010;54:24-38
8. Nordmann P, Dortet L, Poirel L. Carbapenem resistance in Enterobacteriaceae: Here is the storm! Trends Mol Med 2012;18:263-72
9. Queenan AM, Bush K. Carbapenemases: The versatile beta-lactamases. Clin Microbiol Rev 2007;20:440-58
10. Göttig S, Gruber TM, Stecher B, Wichelhaus TA, Kempf VA. In vivo horizontal gene transfer of the carbapenemase OXA-48 during a nosocomial outbreak. Clin Infect Dis 2015;60:1808-15
11. Hrabák J, Chudácková E, Papagiannitsis CC. Detection of carbapenemases in Enterobacteriaceae: A challenge for diagnostic microbiological laboratories. Clin Microbiol Infect 2014;20:839-53
12. Djahmi N, Dunyach-Remy C, Pantel A, Dekhil M, Sotto A, Lavigne JP. Epidemiology of carbapenemase-producing Enterobacteriaceae and Acinetobacter baumannii in Mediterranean countries. Biomed Res Int 2014;2014:305784
13. Nordmann P, Gniadkowski M, Giske CG, Poirel L, Woodford N, Miriagou V; European Network on Carbapenemases. Identifi cation and screening of carbapenemase-producing Enterobacteriaceae. Clin Microbiol Infect 2012;18:432-8
14. Mathlouthi N, Areig Z, Al Bayssari C, Bakour S, et al. Emergence of carbapenemresistant Pseudomonas aeruginosa and Acinetobacter baumannii clinical isolates collected from some Libyan hospitals. Microb Drug Resist 2015;21:335-41
15. Drawz SM, Bonomo RA. Three decades of beta-lactamase inhibitors. Clin Microbiol Rev 2010;23:160-201
16. Docquier JD, Calderone V, De Luca F, Benvenuti M, Giuliani F, Bellucci L, et al. Crystal structure of the OXA-48 beta-lactamase reveals mechanistic diversity among class D carbapenemases. Chem Biol 2009;16:540-7
17. Potron A, Kalpoe J, Poirel L, Nordmann P. European dissemination of a single OXA-48-producing Klebsiella pneumoniae clone. Clin Microbiol Infect 2011;17:E24-6
18. Nordmann P, Naas T, Poirel L. Global spread of Carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 2011;17:1791-8
19. Poirel L, Héritier C, Tolün V, Nordmann P. Emergence of oxacillinasemediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother 2004;48:15-22
20. Evans BA, Amyes SG. OXA ®-lactamases. Clin Microbiol Rev 2014;27: 241-63
21. Oueslati S, Nordmann P, Poirel L. Heterogeneous hydrolytic features for OXA-48-like ®-lactamases. J Antimicrob Chemother 2015;70:1059-63
22. Abdelaziz MO, Bonura C, Aleo A, El-Domany RA, Fasciana T, Mammina C. OXA-163-producing Klebsiella pneumoniae in Cairo, Egypt, in 2009 and 2010. J Clin Microbiol 2012;50:2489-91
23. Teo JW, Kurup A, Lin RT, Hsien KT. Emergence of clinical Klebsiella pneumoniae producing OXA-232 carbapenemase in Singapore. New Microbes New Infect 2013;1:13-5
24. Berger S, Alauzet C, Aissa N, Hénard S, Rabaud C, Bonnet R, et al. Characterization of a new blaOXA-48-carrying plasmid in Enterobacteriaceae. Antimicrob Agents Chemother 2013;57:4064-7
25. Aubert D, Naas T, Héritier C, Poirel L, Nordmann P. Functional characterization of IS1999, an IS4 family element involved in mobilization and expression of beta-lactam resistance genes. J Bacteriol 2006;188:6506-14
26. Poirel L, Bonnin RA, Nordmann P. Genetic features of the widespread plasmid coding for the carbapenemase OXA-48. Antimicrob Agents Chemother 2012;56:559-62
27. Giani T, Conte V, Di Pilato V, Aschbacher R, Weber C, Larcher C, et al. Escherichia coli from Italy producing OXA-48 carbapenemase encoded by a novel Tn1999 transposon derivative. Antimicrob Agents Chemother 2012;56:2211-3
28. Carrër A, Poirel L, Eraksoy H, Cagatay AA, Badur S, Nordmann P. Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey. Antimicrob Agents Chemother 2008;52:2950-4
29. Potron A, Nordmann P, Lafeuille E, Al Maskari Z, Al Rashdi F, Poirel L. Characterization of OXA-181, a carbapenem-hydrolyzing class D betalactamase from Klebsiella pneumoniae. Antimicrob Agents Chemother 2011;55:4896-9
30. Poirel L, Naas T, Nordmann P. Genetic support of extended-spectrum beta-lactamases. Clin Microbiol Infect 2008;14 Suppl 1:75-81
31. Dimou V, Dhanji H, Pike R, Livermore DM, Woodford N. Characterization of Enterobacteriaceae producing OXA-48-like carbapenemases in the UK. J Antimicrob Chemother 2012;67:1660-5
32. Potron A, Nordmann P, Poirel L. Characterization of OXA-204, a carbapenem-hydrolyzing class D ®-lactamase from Klebsiella pneumoniae. Antimicrob Agents Chemother 2013;57:633-6
33. Seiffert SN, Marschall J, Perreten V, Carattoli A, Furrer H, Endimiani A. Emergence of Klebsiella pneumoniae co-producing NDM-1, OXA-48, CTX-M-15, CMY-16, QnrA and ArmA in Switzerland. Int J Antimicrob Agents 2014;44:260-2
34. Carattoli A. Resistance plasmid families in Enterobacteriaceae. Antimicrob Agents Chemother 2009;53:2227-38
35. Carattoli A, Villa L, Poirel L, Bonnin RA, Nordmann P. Evolution of IncA/C blaCMY-2-carrying plasmids by acquisition of the blaNDM-1 carbapenemase gene. Antimicrob Agents Chemother 2012;56:783-6
36. Potron A, Rondinaud E, Poirel L, Belmonte O, Boyer S, Camiade S, et al. Genetic and biochemical characterisation of OXA-232, a carbapenemhydrolysing class D ®-lactamase from Enterobacteriaceae. Int J Antimicrob Agents 2013;41:325-9
37. Nazik H, Aydin S, Albayrak R, Bilgi EA, Yildiz I, Kuvat N,et al.Detection and spread of oxa-48-producing Klebsiella oxytoca isolates in Istanbul, Turkey. Southeast Asian J Trop Med Public Health 2014;45:123-9
38. Thomas CP, Moore LS, Elamin N, Doumith M, Zhang J, Maharjan S, et al. Early (2008-2010) hospital outbreak of Klebsiella pneumoniae producing OXA-48 carbapenemase in the UK. Int J Antimicrob Agents 2013;42:531-6
39. Cuzon G, Ouanich J, Gondret R, Naas T, Nordmann P. Outbreak of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in France. Antimicrob Agents Chemother 2011;55:2420-3
40. Matar GM, Cuzon G, Araj GF, Naas T, Corkill J, Kattar MM, et al. Oxacillinase-mediated resistance to carbapenems in Klebsiella pneumoniae from Lebanon. Clin Microbiol Infect 2008;14:887-8
41. Cuzon G, Naas T, Bogaerts P, Glupczynski Y, Huang TD, Nordmann P. Plasmid-encoded carbapenem-hydrolyzing beta-lactamase OXA-48 in an imipenem-susceptible Klebsiellapneumoniae strain from Belgium. Antimicrob Agents Chemother 2008;52:3463-4
42. Livermore DM. Has the era of untreatable infections arrived? J Antimicrob Chemother 2009;64 Suppl 1:i29-36
43. Cuzon G, Naas T, Lesenne A, Benhamou M, Nordmann P. Plasmid-mediated carbapenem-hydrolysing OXA-48 beta-lactamase in Klebsiellapneumoniae from Tunisia. Int J Antimicrob Agents 2010;36:91-3
44. Benouda A, Touzani O, Khairallah MT, Araj GF, Matar GM. First detection of oxacillinase-mediated resistance to carbapenems in Klebsiellapneumoniae from Morocco. Ann Trop Med Parasitol 2010;104:327-30
45. Dortet L, Poirel L, Al Yaqoubi F, Nordmann P. NDM-1, OXA-48 and OXA-181 carbapenemase-producing Enterobacteriaceae in Sultanate of Oman. Clin Microbiol Infect 2012;18:E144-8
46. Kalpoe JS, Al Naiemi N, Poirel L, Nordmann P. Detection of an Ambler class D OXA-48-type ®-lactamase in a Klebsiellapneumoniae strain in The Netherlands. J Med Microbiol 2011;60:677-8
47. Poirel L, Potron A, Nordmann P. OXA-48-like carbapenemases: The phantom menace. J Antimicrob Chemother 2012;67:1597-606
48. Aktas Z, Kayacan CB, Schneider I, Can B, Midilli K, Bauernfeind A. Carbapenem-hydrolyzing oxacillinase, OXA-48, persists in Klebsiella pneumoniae in Istanbul, Turkey. Chemotherapy 2008;54:101-6
49. Gülmez D, Woodford N, Palepou MF, Mushtaq S, Metan G, Yakupogullari Y, et al. Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss. Int J Antimicrob Agents 2008;31:523-6
50. Moquet O, Bouchiat C, Kinana A, Seck A, Arouna O, Bercion R, et al. Class D OXA-48 carbapenemase in multidrug-resistant enterobacteria, Senegal. Emerg Infect Dis 2011;17:143-4
51. Pitart C, Solé M, Roca I, Fàbrega A, Vila J, Marco F. First outbreak of a plasmid-mediated carbapenem-hydrolyzing OXA-48 beta-lactamase in Klebsiella pneumoniae in Spain. Antimicrob Agents Chemother 2011;55:4398-401
52. Dautzenberg MJ, Ossewaarde JM, Kraker ME, van der Zee A, van Burgh S, Greeff SC, et al. Successful control of a hospital-wide outbreak of OXA-48 producing Enterobacteriaceae in the Netherlands, 2009 to 2011. Euro Surveill 2014;19. pii: 20723
53. Glupczynski Y, Huang TD, Bouchahrouf W, Rezende de Castro R, Bauraing C, Gérard M, et al. Rapid emergence and spread of OXA-48-producing carbapenem-resistant Enterobacteriaceae isolates in Belgian hospitals. Int J Antimicrob Agents 2012;39:168-72
54. Pfeifer Y, Schlatterer K, Engelmann E, Schiller RA, Frangenberg HR, Stiewe D, et al. Emergence of OXA-48-type carbapenemase-producing Enterobacteriaceae in German hospitals. Antimicrob Agents Chemother 2012;56:2125-8
55. Liapis E, Pantel A, Robert J, Nicolas-Chanoine MH, Cavalié L, Mee-Marquet N, et al. Molecular epidemiology of OXA-48-producing Klebsiella pneumoniae in France. Clin Microbiol Infect 2014;20:O1121-3
56. Kocsis E, Savio C, Piccoli M, Cornaglia G, Mazzariol A. Klebsiella pneumoniae harbouring OXA-48 carbapenemase in a Libyan refugee in Italy. Clin Microbiol Infect 2013;19:E409-11
57. Paño-Pardo JR, Ruiz-Carrascoso G, Navarro-San Francisco C, Gómez-Gil R, Mora-Rillo M, Romero-Gómez MP, et al. Infections caused by OXA-48-producing Klebsiella pneumoniae in a tertiary hospital in Spain in the setting of a prolonged, hospital-wide outbreak. J Antimicrob Chemother 2013;68:89-96
58. Doi Y, O'Hara JA, Lando JF, Querry AM, Townsend BM, Pasculle AW, et al. Co-production of NDM-1 and OXA-232 by Klebsiella pneumoniae. Emerg Infect Dis 2014;20:163-5
59. Lascols C, Peirano G, Hackel M, Laupland KB, Pitout JD. Surveillance and molecular epidemiology of Klebsiella pneumoniae isolates that produce carbapenemases: First report of OXA-48-like enzymes in North America. Antimicrob Agents Chemother 2013;57:130-6
60. Gomez S, Pasteran F, Faccone D, Bettiol M, Veliz O, De Belder D, et al. Intrapatient emergence of OXA-247: A novel carbapenemase found in a patient previously infected with OXA-163-producing Klebsiella pneumoniae. Clin Microbiol Infect 2013;19:E233-5
61. Castanheira M, Mendes RE, Woosley LN, Jones RN. Trends in carbapenemase-producing Escherichia coli and Klebsiella spp. from Europe and the Americas: Report from the SENTRY antimicrobial surveillance programme (2007-09). J Antimicrob Chemother 2011;66:1409-11
62. Williamson DA, Heffernan H, Sidjabat H, Roberts SA, Paterson DL, Smith M, et al. Intercontinental transfer of OXA-181-producing Klebsiella pneumoniae into New Zealand. J Antimicrob Chemother 2011;66:2888-90
63. Balm MN, Ngan G, Jureen R, Lin RT, Teo JW. OXA-181-producing Klebsiella pneumoniae establishing in Singapore. BMC Infect Dis 2013;13:58
64. Kayama S, Koba Y, Shigemoto N, Kuwahara R, Kakuhama T, Kimura K, et al. Imipenem-susceptible, meropenem-resistant Klebsiellapneumoniae producing OXA-181 in Japan. Antimicrob Agents Chemother 2015;59:1379-80
65. Castanheira M, Deshpande LM, Mathai D, Bell JM, Jones RN, Mendes RE. Early dissemination of NDM-1-and OXA-181-producing Enterobacteriaceae in Indian hospitals: Report from the SENTRY Antimicrobial Surveillance Program, 2006-2007. Antimicrob Agents Chemother 2011;55:1274-8
66. Lascols C, Hackel M, Marshall SH, Hujer AM, Bouchillon S, Badal R, et al. Increasing prevalence and dissemination of NDM-1 metallo-®-lactamase in India: Data from the SMART study (2009). J Antimicrob Chemother 2011;66:1992-7
67. Khajuria A, Praharaj AK, Kumar M, Grover N. Emergence of Escherichia coli, Co-Producing NDM-1 and OXA-48 Carbapenemases, in Urinary Isolates, at a Tertiary Care Centre at Central India. J Clin Diagn Res 2014;8:DC01-4
68. Shanthi M, Sekar U, Bramhne HG. OXA-181 Beta Lactamase is not a Major Mediator of Carbapenem Resistance in Enterobacteriaceae. J Clin Diagn Res 2013;7:1986-8
69. Shibl A, Al-Agamy M, Memish Z, Senok A, Khader SA, Assiri A. The emergence of OXA-48-and NDM-1-positive Klebsiellapneumoniae in Riyadh, Saudi Arabia. Int J Infect Dis 2013;17:e1130-3
70. Nordmann P, Poirel L. Strategies for identifi cation of carbapenemaseproducing Enterobacteriaceae. J Antimicrob Chemother 2013;68:487-9
71. Levast M, Poirel L, Carrër A, Deiber M, Decroisette E, Mallaval FO, et al. Transfer of OXA-48-positive carbapenem-resistant Klebsiellapneumoniae from Turkey to France. J Antimicrob Chemother 2011;66:944-5
72. Goren MG, Chmelnitsky I, Carmeli Y, Navon-Venezia S. Plasmid-encoded OXA-48 carbapenemase in Escherichia coli from Israel. J Antimicrob Chemother 2011;66:672-3
73. Balkan II, Aygün G, Aydin S, Mutcali SI, Kara Z, Kuskucu M, et al. Blood stream infections due to OXA-48-like carbapenemaseproducing Enterobacteriaceae: Treatment and survival. Int J Infect Dis 2014;26:51-6
74. Yamamoto M, Pop-Vicas AE. Treatment for infections with carbapenemresistant Enterobacteriaceae: What options do we still have? Crit Care 2014;18:229
75. Ehmann DE, Jahic H, Ross PL, Gu RF, Hu J, Kern G, et al. Avibactam is a covalent, reversible, non-®-lactam-lactamase inhibitor. Proc Natl Acad® Sci U S A 2012;109:11663-8
76. Aktas Z, Kayacan C, Oncul O. In vitro activity of avibactam (NXL104) in combination with ®-lactams against Gram-negative bacteria, including OXA-48 ®-lactamase-producing Klebsiella pneumoniae. Int J Antimicrob Agents 2012;39:86-9
77. Wiskirchen DE, Nordmann P, Crandon JL, Nicolau DP. Effi cacy of humanized carbapenem exposures against New Delhi metallo-®-lactamase (NDM-1)-producing enterobacteriaceae in a murine infection model. Antimicrob Agents Chemother 2013;57:3936-40
78. Mimoz O, Grégoire N, Poirel L, Marliat M, Couet W, Nordmann P. Broadspectrum ®-lactam antibiotics for treating experimental peritonitis in mice due to Klebsiella pneumoniae producing the carbapenemase OXA-48. Antimicrob Agents Chemother 2012;56:2759-60
79. Falagas ME, Lourida P, Poulikakos P, Rafailidis PI, Tansarli GS. Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: Systematic evaluation of the available evidence. Antimicrob Agents Chemother 2014;58:654-63
80. Livermore DM, Warner M, Mushtaq S, Doumith M, Zhang J, Woodford N. What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofl oxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline. Int J Antimicrob Agents 2011;37:415-9
81. Zarkotou O, Pournaras S, Voulgari E, Chrysos G, Prekates A, Voutsinas D, et al. Risk factors and outcomes associated with acquisition of colistinresistant KPC-producing Klebsiella pneumoniae: A matched case-control study. J Clin Microbiol 2010;48:2271-4
82. Anthony KB, Fishman NO, Linkin DR, Gasink LB, Edelstein PH, Lautenbach E. Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline. Clin Infect Dis 2008;46:567-70
83. Tumbarello M, Viale P, Viscoli C, Trecarichi EM, Tumietto F, Marchese A, et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: Importance of combination therapy. Clin Infect Dis 2012;55:943-50
84. Arana DM, Saez D, García-Hierro P, Bautista V, Fernández-Romero S, Ángel Cal M, et al. Concurrent interspecies and clonal dissemination of OXA-48 carbapenemase. Clin Microbiol Infect 2015;21:148.e1-4
85. Vasoo S, Cunningham SA, Kohner PC, Simner PJ, Mandrekar JN, Lolans K, et al. Comparison of a novel, rapid chromogenic biochemical assay, the Carba NP test, with the modifi ed Hodge test for detection of carbapenemaseproducing Gram-negative bacilli. J Clin Microbiol 2013;51:3097-101
86. Girlich D, Poirel L, Nordmann P. Value of the modifi ed Hodge test for detection of emerging carbapenemases in Enterobacteriaceae. J Clin Microbiol 2012;50:477-9
87. Hartl R, Widhalm S, Kerschner H, Apfalter P. Temocillin and meropenem to discriminate resistance mechanisms leading to decreased carbapenem susceptibility with focus on OXA-48 in Enterobacteriaceae. Clin Microbiol Infect 2013;19:E230-2
88. Livermore DM, Tulkens PM. Temocillin revived. J Antimicrob Chemother 2009;63:243-5
89. Woodford N, Pike R, Meunier D, Loy R, Hill R, Hopkins KL. In vitro activity of temocillin against multidrug-resistant clinical isolates of Escherichia coli, Klebsiella spp. and Enterobacter spp. and evaluation of high-level temocillin resistance as a diagnostic marker for OXA-48 carbapenemase. J Antimicrob Chemother 2014;69:564-7
90. Andrews JM, Jevons G, Walker R, Ashby J, Fraise AP. Temocillin susceptibility by BSAC methodology. J Antimicrob Chemother 2007;60:185-7
91. Van Dijk K, Voets GM, Scharringa J, Voskuil S, Fluit AC, Rottier WC, et al. A disc diffusion assay for detection of class A, B and OXA-48 carbapenemases in Enterobacteriaceae using phenyl boronic acid, dipicolinic acid and temocillin. Clin Microbiol Infect 2014;20:345-9
92. Cohen Stuart J, Voets G, Rottier W, Voskuil S, Scharringa J, Van Dijk K, et al. Evaluation of the Oxoid Brilliance™ CRE Agar for the detection of carbapenemase-producing Enterobacteriaceae. Eur J Clin Microbiol Infect Dis 2013;32:1445-9
93. Vrioni G, Daniil I, Voulgari E, Ranellou K, Koumaki V, Ghirardi S, et al. Comparative evaluation of a prototype chromogenic medium (ChromID CARBA) for detecting carbapenemase-producing Enterobacteriaceae in surveillance rectal swabs. J Clin Microbiol 2012;50:1841-6
94. Girlich D, Anglade C, Zambardi G, Nordmann P. Comparative evaluation of a novel chromogenic medium (chromID OXA-48) for detection of OXA-48 producing Enterobacteriaceae. Diagn Microbiol Infect Dis 2013;77:296-300
95. Dortet L, Poirel L, Nordmann P. Rapid identifi cation of carbapenemase types in Enterobacteriaceae and Pseudomonas spp. by using a biochemical test. Antimicrob Agents Chemother 2012;56:6437-40
96. Dortet L, Poirel L, Nordmann P. Further proofs of concept for the Carba NP test. Antimicrob Agents Chemother 2014;58:1269
97. Tijet N, Boyd D, Patel SN, Mulvey MR, Melano RG. Evaluation of the Carba NP test for rapid detection of carbapenemase-producing Enterobacteriaceae and Pseudomonasaeruginosa. Antimicrob Agents Chemother 2013;57:4578-80
98. Pires J, Novais A, Peixe L. Blue-carba, an easy biochemical test for detection of diverse carbapenemase producers directly from bacterial cultures. J Clin Microbiol 2013;51:4281-3
99. Kaase M, Szabados F, Wassill L, Gatermann SG. Detection of carbapenemases in Enterobacteriaceae by a commercial multiplex PCR. J Clin Microbiol 2012;50:3115-8
100. Nijhuis R, Samuelsen O, Savelkoul P, van Zwet A. Evaluation of a new real-time PCR assay (Check-Direct CPE) for rapid detection of KPC, OXA-48, VIM, and NDM carbapenemases using spiked rectal swabs. Diagn Microbiol Infect Dis 2013;77:316-20
101. Naas T, Cuzon G, Bogaerts P, Glupczynski Y, Nordmann P. Evaluation of a DNA microarray (Check-MDR CT102) for rapid detection of TEM, SHV, and CTX-M extended-spectrum ®-lactamases and of KPC, OXA-48, VIM, IMP, and NDM-1 carbapenemases. J Clin Microbiol 2011;49:1608-13
102. Sauget M, Cabrolier N, Manzoni M, Bertrand X, Hocquet D. Rapid, sensitive and specifi c detection of OXA-48-like-producing Enterobacteriaceae by matrix-assisted laser desorption/ionization time-of-fl ight mass spectrometry. J Microbiol Methods 2014;105:88-91
103. Lafeuille E, Laouira S, Sougakoff W, Soulier-Escrihuela O, Leconte J, Garrec H, et al. Detection of OXA-48-like carbapenemase genes by the Xpert® Carba-R test: Room for improvement. Int J Antimicrob Agents 2015;45:441-2